Medicine and Dentistry
Patient
71%
Lymphoma
57%
Transplantation
50%
Autologous Hematopoietic Stem Cell Transplantation
50%
Survival
50%
Regulatory T Cell
50%
Spontaneous Remission
50%
Patient with Non-Hodgkins Lymphoma
50%
Inpatient
50%
Cell Function
50%
Nicotinamide
50%
Natural Killer Cell
50%
Cell Transplantation
33%
Hematopoietic Cell
33%
Non-Hodgkin Lymphoma
26%
Adoptive Transfer
21%
Interleukin 15
14%
Ex Vivo
14%
Lymphocyte
11%
Immunocompetent Cell
8%
Overall Survival
8%
Monoclonal Antibody
7%
Cell Therapy
7%
L Selectin
7%
Multiple Myeloma
7%
Leukemia
7%
Oxidative Stress
7%
Cell Adhesion Molecule
7%
Neoplasm
7%
Cell Survival
7%
Cytokine Production
7%
Development
7%
Lymph Node
7%
Blood
7%
Clinical Trial
7%
Cytotoxicity
7%
Forkhead Transcription Factor
7%
Tissues
7%
Rituximab
7%
Cells
7%
Glucose
7%
Cancer Therapy
7%
Immunology and Microbiology
Natural Killer Cell
100%
Multiple Myeloma
57%
Transplantation
50%
Regulatory T Cell
50%
Survival
50%
Autologous Transplantation
50%
Cell Expansion
50%
Autologous Hematopoietic Stem Cell Transplantation
50%
Cell Function
50%
Cell Transplantation
47%
Cytomegalovirus
28%
Cell Culture
14%
Interleukin 15
14%
Association
11%
Lymphocyte
11%
Overall Survival
8%
Immunocompetent Cell
8%
Immunological Memory
7%
Cytotoxicity
7%
Cytokine Production
7%
Oxidative Stress
7%
Degradation
7%
Rituximab
7%
Monoclonal Antibodies
7%
Experiment
7%
Cell Survival
7%
Bone Marrow
7%
Electric Potential
7%
Tissues
7%
Adhesion Molecule
7%
Forkhead Transcription Factor
7%
Cells
7%
Development
7%
L-Selectin
7%